Skip Navigation

Cardiovascular Research 1998 37(3):765-771; doi:10.1016/S0008-6363(97)00291-5
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Holm, P.
Right arrow Articles by Franco-Cereceda, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holm, P.
Right arrow Articles by Franco-Cereceda, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo

Peter Holm*, Jan Liska and Anders Franco-Cereceda

Department of Thoracic Surgery, Karolinska Hospital, S-171 76 Stockholm, Sweden

* Corresponding author. Tel.: +46 (8) 51775546; Fax: +46 (8) 322701.

Objective: Elevated levels of the potent vasoactive peptide endothelin (ET), have been found in pathophysiological conditions associated with pulmonary hypertension. In this study, we have investigated the effects of the ETA receptor antagonist, BMS-182874, on hypoxic pulmonary hypertension in pigs. Methods: Pigs were subjected to acute, intermittent 15-min periods of hypoxia (FiO2 0.1). Following a first hypoxia establishing hypoxic baseline values, vehicle or BMS-182874 (10 or 30 mg/kg) was administered i.v. before a second hypoxic period. In separate groups of animals, the effects of the nitric oxide synthase inhibitor N{omega}-nitro-L-arginine (L-NNA) in combination with BMS-182874 (10 mg) during repeated hypoxia were investigated. The ET-1-blocking properties of BMS-182874 were studied in vivo by infusion of ET-1 during normoxia and in vitro using isolated porcine pulmonary arteries. Results: The hypoxia-evoked increase in mean pulmonary artery pressure was reduced by administration of BMS-182874 (10 mg/kg i.v.; from 42±8 to 34±4 mmHg, P<0.05 and 30 mg/kg i.v.; from 38±4 to 30±5 mmHg, P<0.05). In addition, BMS-182874 at 30 mg/kg reduced the pulmonary vascular resistance during hypoxia (from 7.4±1.5 to 5.3±1.1 mmHg·min·l–1 P<0.05). The hemodynamic response to repeated hypoxia was reproducible in control animals and unaffected by the cyclo-oxygenase inhibitor diclophenac (3 mg/kg). Infusion of L-NNA alone resulted in an augmented pulmonary vasoconstriction during hypoxia; pulmonary arterial pressure from 35±6 to 43±9 mmHg; P<0.05 and vascular resistance from 7.2±1.1 to 9.9±1.8 mmHg·min·l–1; P<0.05. L-NNA in combination with BMS-182874 (10 mg/kg) resulted in a hypoxic pulmonary vasoconstriction of similar magnitude as hypoxic baseline. In addition, BMS-182874 reduced the hemodynamic response to ET-1 in normoxic pigs and competitively antagonized the vasoconstrictor effect of ET-1 in isolated porcine pulmonary arteries. Conclusions: The non-peptide, selective ETA receptor antagonist, BMS-182874, reduces hypoxic pulmonary vasoconstriction in pigs. The reduction in pulmonary vascular response to hypoxia following BMS-182874 is at least partly independent of nitric oxide.

KEYWORDS BMS-182874; Endothelin; Hypoxia; Pig; Pulmonary hypertension


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Petersen, M. Deja, R. Bartholdy, B. Donaubauer, S. Laudi, R. C. E. Francis, W. Boemke, U. Kaisers, and T. Busch
Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R601 - R605.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Modesti, S. Vanni, M. Morabito, A. Modesti, M. Marchetta, T. Gamberi, F. Sofi, G. Savia, G. Mancia, G. F. Gensini, et al.
Role of Endothelin-1 in Exposure to High Altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) Study
Circulation, September 26, 2006; 114(13): 1410 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Merkus, B. Houweling, A. Mirza, F. Boomsma, A. H van den Meiracker, and D. J Duncker
Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation
Cardiovasc Res, September 1, 2003; 59(3): 745 - 754.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Hubloue, D. Biarent, S. A. Kafi, G. Bejjani, F. Kerbaul, R. Naeije, and M. Leeman
Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
Eur. Respir. J., January 1, 2003; 21(1): 19 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Johnson, A. Nohria, L. Garrett, J. C. Fang, J. Igo, M. Katai, P. Ganz, and M. A. Creager
Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H568 - H575.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Liu, J. S. K. Sham, L. A. Shimoda, and J. T. Sylvester
Hypoxic constriction of porcine distal pulmonary arteries: endothelium and endothelin dependence
Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L856 - L865.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. S. K. Sham, B. R. Crenshaw Jr., L.-H. Deng, L. A. Shimoda, and J. T. Sylvester
Effects of hypoxia in porcine pulmonary arterial myocytes: roles of KV channel and endothelin-1
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L262 - L272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Hocher, A. Schwarz, K. A. Fagan, C. Thöne-Reineke, K. El-Hag, H. Kusserow, S. Elitok, C. Bauer, H.-H. Neumayer, D. M. Rodman, et al.
Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 19 - 26.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
B.M Weiss and O.M Hess
Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives
Eur. Heart J., January 2, 2000; 21(2): 104 - 115.
[PDF]


Home page
J. Appl. Physiol.Home page
S. Doi, N. Smedira, and P. A. Murray
Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation
J Appl Physiol, January 1, 2000; 88(1): 210 - 218.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.